► 01:25 Nilotinib Therapy in Frontline CML CML Content Hub Timothy Hughes, of SAHMRI, discusses #frontline #nilotinib therapy in #CML.
► 06:40 Successful Treatment-Free Remission in Patients With CML After TKI Discontinuation CML Content Hub @FadiHaddad_MD, of @MDAndersonNews, discusses treatment-free remission in #CML.
► 13:25 An Overview of Research Program for Pompe Disease Pompe Disease Content Hub Priya Kishnani, MD, of @DukeMedSchool, discusses #translational #research on #PompeDisease.
► 1:37:47 Small Molecule Inhibitor Reduces Glycogen in Preclinical Mouse Models of Pompe Disease Pompe Disease Content Hub Julie Ullman, PhD, of @MazeInBiotech, discusses #preclinical #results on #MZE001 for #PompeDisease.
► 02:10 Multidisciplinary Approach to Managing Pompe Disease Pompe Disease Content Hub Priya Kishnani, MD, of @DukeMedSchool, discusses #multidisciplinary care for #PompeDisease.
► 54:32 Newborn Screening for Pompe Disease Pompe Disease Content Hub Damara Ortiz, MD, of @ChildrensPgh, discusses #screening for #PompeDisease.
► 5:28 Liquid Biopsy in Lung Cancer Decreases Time to Treatment Oncology Miguel Garcia-Pardo, MD, of @pmcancercentre, discusses #liquidbiopsy in #lungcancer.
► 22:34 Roundtable on VEGF TKI/Immune Checkpoint Inhibitor Therapy in Renal Cell Cancer Nephrology @motzermd, @DrChoueiri, @AlbigesL, and Robert A Figlin, MD, discuss combined #TKI and #ICI therapy in #RCC.
► 5:30 Importance of Screening, Early Detection, and Precision Medicine in Myeloma Multiple Myeloma Content Hub @IreneGhobrial, of @DanaFarber, discusses early #screening in #myeloma.
► 12:20 Phase 3 Trial Data for Next-Generation Enzyme Therapy in Pompe Disease Pompe Disease Content Hub Priya Kishnani, MD, of @DukeOTC, discusses #treatment for #PompeDisease.
